DalsnaFinance › Analyst accuracy › RBC Capital Markets › AMGN target
RBC raises Amgen stock price target to $400 on strong quarter
RBC Capital raised its price target on Amgen Inc. (NASDAQ:AMGN) to $400 from $370 on Tuesday while maintaining an Outperform rating.
A fact about what RBC Capital Markets published, as reported by Investing.com Canada, not a recommendation from Dalsna Finance; RBC Capital Markets is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.